Columbia University Herbert Irving Cancer Center — New York, New York

Columbia University Herbert Irving Cancer Center is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Columbia University Herbert Irving Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University Herbert Irving Cancer Center?

Columbia University Herbert Irving Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University Herbert Irving Cancer Center conducted?

Columbia University Herbert Irving Cancer Center has 1 clinical trials on record. Their work covers Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma.

Is Columbia University Herbert Irving Cancer Center accredited by Crixeo Health?

Columbia University Herbert Irving Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University Herbert Irving Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.